Is retatrutide more effective than Ozempic?
Indirect comparisons suggest that retatrutide produces greater weight loss than semaglutide (Ozempic/Wegovy), but the drug has not yet been approved and no direct head-to-head trial exists. If you want to be treated now, semaglutide or tirzepatide are the available choices.
Retatrutide acts on three hormone receptors simultaneously, whereas semaglutide targets only one. In network meta-analyses that compare multiple studies indirectly, retatrutide 12 mg comes out on top among all agents examined: an average weight loss of 22% after 48 weeks compared with placebo. Semaglutide 2.4 mg (sold at a higher dose for obesity as Wegovy) achieves around 14% weight loss in the same comparison. That looks like a substantial difference, but it is important to know that this is an indirect comparison, not a direct head-to-head trial.
There is in fact no study in which people were randomly assigned to either a retatrutide group or a semaglutide group. All claims about 'who wins' come from statistical network comparisons. Such analyses can be distorted by differences in study populations, study duration, and the way outcomes are measured. The certainty about the precise difference is therefore limited.
On top of that, retatrutide is not yet on the market at all. The large phase 3 studies are still ongoing and must confirm long-term safety and efficacy. The available safety data come mainly from a single phase 2 study. The most commonly reported side effects are gastrointestinal complaints such as nausea, vomiting, and diarrhoea. These occurred in 47 to 84% of participants, were predominantly mild, and decreased when the starting dose was lower. Heart rate also rose temporarily, but whether that matters in the long term is still unknown.
If you want to do something about your weight now and qualify for medication, retatrutide is not an option. Semaglutide and tirzepatide are approved and available. Based on the indirect comparisons, tirzepatide (which also acts on two receptors) already appears to be more effective than semaglutide, and retatrutide appears to go beyond that still. But until the phase 3 data are in, that remains a promise, not a certainty.
All comparisons between retatrutide and semaglutide are based on indirect network meta-analyses (PMID 39305981, 39761578). There are no direct head-to-head RCTs. Safety data for retatrutide come mainly from a single phase 2 study (PMID 37366315). The phase 3 programme (TRIUMPH) is still ongoing (PMID 40563436, 38626998).
Does orforglipron, the weight-loss pill, work as well as Ozempic?
Orforglipron works well for blood sugar and weight, but in obesity it is probably less powerful than injectable Ozempic and causes side effects more often. If you want to avoid the injection pen it is a serious option, but discuss it with your doctor, because the direct comparison on weight loss is still missing.
What are the side effects of Ozempic?
Semaglutide causes digestive complaints, mainly nausea, in one in four users; these usually resolve over time. Rarer signals such as eye-nerve damage require medical follow-up, so always use this medication under the supervision of a doctor.
What are the side effects and risks of retatrutide?
Retatrutide causes gastrointestinal complaints in many users and a temporary increase in heart rate; serious side effects were rare in the available studies, but long-term safety remains largely unknown. Slow dose escalation helps to limit complaints, but always discuss use with your doctor.
What is the effect of Ozempic combined with alcohol use?
Semaglutide reduces the craving for alcohol and the number of heavy drinking episodes in people with an alcohol use disorder. It is not an officially approved treatment for alcohol problems, but speak to your doctor if you are using semaglutide and have questions about your alcohol use.
What are the effects of microdosing with Ozempic?
Some people using Ozempic report fewer digestive complaints at a lower dose, and anecdotal reports suggest this may improve adherence to treatment. Clinical evidence for this is currently lacking.
Do GLP-1 medications (such as Ozempic) help you age more healthily?
For people with cardiovascular disease, kidney disease, or fatty liver disease, GLP-1 medications offer proven benefits that are also relevant at older ages. As an anti-ageing intervention in healthy people, their use is not yet supported by evidence.